Michael Mithoefer, M.D is the senior medical director for medical affairs at the Multidisciplinary Association for Psychedelic Studies (MAPS). He has nearly 30 years of experience treating trauma patients and has been board-certified in Psychiatry, Emergency Medicine, and Internal Medicine. In his time at MAPS, Dr. Mithoefer and his wife have conducted two of the six MAPS-sponsored Phase 2 clinical trials testing MDMA-assisted psychotherapy for PTSD. He has also piloted a study treating couples with MDMA-assisted psychotherapy combined with Cognitive-Behavioral Conjoint Therapy.
MDMA-Assisted Psychotherapy: How Different is it from Other Psychotherapy?
Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study
Treating PTSD with MDMA: Dr. Michael Mithoefer
MDMA-assisted psychotherapy for PTSD approved by FDA